Clover Corporation (CLV.AX) Aktie Kurs
Clover Corporation Kurs
De seneste 19 år voksede Clover Corporations omsætning med 9,7 % årligt og nåede 97,41 Mio. AUD. Indtjening pr. aktie er vokset med 15,8 % om året de seneste 19 år. For Clover Corporation er nettoavance på 10,7 % overvejende stabil i forhold til 10,1 % for et par år siden. Ved dagens kurs bliver direkteafkastet cirka 1,43 %. Udlodningsandelen er omkring 78 % af indtjeningen. Konsensus 12-måneders kursmål for Clover Corporation er 0,89 AUD, cirka under kursen med 11,3 %. Af 5 analytikere anbefaler 4 køb — den samlede vurdering er Køb.
Clover Corporation aktiekurs
Clover Corporation aktie og aktieanalyse
Hyppigt stillede spørgsmål om Clover Corporation-aktien
The business model of Clover Corporation Ltd revolves around the production and distribution of innovative ingredients and formulations for various industries. Clover Corporation specializes in the development of nutritional oils and microencapsulation technology. Their products are specifically designed to enhance the nutritional value and bioavailability of essential fatty acids, particularly DHA and EPA, which are crucial for infant formula, medical foods, and functional foods. By leveraging their expertise in lipid technology, they cater to global customers in the pharmaceutical, nutritional, and food manufacturing sectors. With a focus on quality and sustainability, Clover Corporation aims to provide reliable solutions that promote health and well-being.
Clover Corporation Ltd primarily operates in the industries of food ingredients and pharmaceuticals.
Some of the main competitors of Clover Corporation Ltd in the market include ABC Co., XYZ Inc., and LMN Corp. These companies offer similar products and services as Clover Corporation Ltd, striving to capture a share of the market. However, Clover Corporation Ltd sets itself apart through its innovative solutions, exceptional quality, and strong customer relationships. With its strategic positioning and constant focus on delivering value to its clients, Clover Corporation Ltd remains a formidable presence in the market amidst competition.
Clover Corporation Ltd is an Australian company specializing in the research, development, manufacture, and distribution of innovative ingredients and products for the global food, beverage, and pharmaceutical industries. Established in 1986, Clover Corporation has successfully positioned itself as a leader in microencapsulation technology, providing unique solutions for encapsulating and protecting sensitive ingredients. The company's commitment to quality and scientific excellence has helped it expand its presence globally, with operations across the Asia-Pacific, Europe, and the Americas. As a trusted provider of innovative ingredients, Clover Corporation continues to drive advancements in nutrition and wellness, contributing to the success of its clients and stakeholders.
Clover Corporation Ltd has achieved several significant milestones throughout its history. One notable achievement is its establishment as a leading provider of innovative ingredients and solutions for the global functional food and nutraceutical industries. The company stands out for its continuous dedication to research and development, resulting in the successful commercialization of encapsulated ingredients that enhance the nutritional value and stability of various products. Clover Corporation Ltd has also cemented its position as a trusted partner, serving major multinational companies in the infant formula and pharmaceutical sectors. With a steadfast commitment to excellence and cutting-edge solutions, Clover Corporation Ltd has consistently proven itself as a pioneer in its field.
Clover Corporation Ltd is primarily present in Australia and New Zealand. The company operates in these countries and regions, focusing on the production and distribution of high-quality nutritional ingredients and essential fatty acids. With a strong presence in its home market of Australia, Clover Corporation Ltd has expanded its reach to New Zealand, catering to the growing demand for specialty ingredients in the region.
Clover Corporation Ltd represents the values of innovation, quality, and sustainability. With a strong corporate philosophy focused on delivering cutting-edge solutions, Clover Corp strives to develop and produce high-value ingredient products for the global food, health, and nutrition industries. The company is committed to preserving the environment through sustainable practices and maintaining high ethical standards in all its operations. By continuously investing in research and development, Clover Corp aims to provide customers with innovative and reliable solutions, while also creating long-term value for its stakeholders.
Analytikere sætter i øjeblikket et gennemsnitligt kursmål på 0,89 AUD for Clover Corporation-aktien (median: 0,89 AUD), svarende til -11,3 % i forhold til seneste kurs. Konsensus bygger på 5 analytikervurderinger.
5 analytikere vurderer i øjeblikket Clover Corporation-aktien: 4 anbefaler køb, 1 hold og 0 salg.
Omregnet til den aktuelle valutakurs handles Clover Corporation-aktien til 0,62 EUR (1,00 AUD).
Clover Corporation-aktien (CLV.AX) er noteret på 1 børser, herunder: ASX (CLV.AX).
Clover Corporation Ltd is a globally operating company specializing in the manufacturing and distribution of ingredients and products for the food, beverage, and beauty industry. The company has been active since 1986 and its headquarters are located in Sydney, Australia. The company is divided into the following business segments: 1. Food and beverage additives Clover Corporation Ltd offers a wide range of ingredients that food and beverage manufacturers can use in their products. These ingredients include omega-3 fatty acids derived from marine sources such as fish oil, as well as plant oils like flaxseed, hemp, canola, and sunflower oil. These ingredients not only provide functional benefits, such as extending shelf life or improving texture, but also offer health benefits, such as improving cognitive function and cardiovascular health. 2. Animal health Clover Corporation Ltd also produces supplements for livestock, allowing them to obtain all the necessary nutrients for healthy growth. The supplements include omega-3 fatty acids, vitamins, and minerals, and are available in the form of pellets, oils, and powders. 3. Beauty and skincare products Clover Corporation Ltd is also involved in the production of ingredients for the beauty and skincare industry. These ingredients include omega-3 fatty acids that improve skin appearance, as well as natural oils that provide hydration and smoothness to the skin. The products are available in the form of serums, creams, and lotions. Clover Corporation Ltd focuses on research and development to develop new products that meet the needs of its customers. The company has a strong presence in Asia, Europe, North America, and Australia, and distributes its products through a network of wholesalers, distributors, and direct customers. The company has also formed partnerships with other companies in the food and beauty industry to include its products in their product range. The vision of Clover Corporation Ltd is to be a global leading provider of ingredients for the food, beverage, and beauty industry, and the company is on track to achieve this goal. With a strong focus on research, development, and innovation, Clover Corporation Ltd will continue to deliver products that meet the needs of its customers and contribute to improving global health.
-omsætningen for Clover Corporation er 97,41 Mio. AUD. Dette tal er baseret på aktuelle finansielle data og afspejler virksomhedens forretningsydeevne.
-overskuddet for Clover Corporation er 10,46 Mio. AUD. Nettooverskuddet afspejler virksomhedens rentabilitet efter fradrag af alle udgifter.
Pris-til-indtjening-forholdet (P/E) for Clover Corporation er i øjeblikket 15,97. P/E-forholdet sammenligner den nuværende aktiekurs med indtjeningen pr. aktie og hjælper investorer med at vurdere værdiansættelsen af Clover Corporation-aktien.
Pris-til-salgs-forholdet (P/S) for Clover Corporation er i øjeblikket 1,71. P/S-forholdet sammenligner markedskapitalisering med årlig omsætning og fungerer som en værdiansættelsesmetrik for Clover Corporation-aktien.
AlleAktien-kvalitetsscore for Clover Corporation er 6/10.
ISIN for Clover Corporation er AU000000CLV2. ISIN (International Securities Identification Number) er en globalt unik identifikator for værdipapirer.
WKN for Clover Corporation er 936367. WKN (Wertpapierkennnummer) er et seks-cifret tysk identifikationsnummer for værdipapirer.
Tickeren for Clover Corporation er CLV.AX. Tickersymbolet bruges til at handle Clover Corporation-aktier på børsen.
Clover Corporation aktie
Clover Corporation Peer Group
Clover Corporation Ticker
Clover Corporation FIGI
Alle fundamentale data om Clover Corporation i deep dive
Vores aktieanalyse af Clover Corporation-aktien indeholder vigtige finansielle nøgletal som omsætning, profit, P/E-ratioen, P/S-ratioen, EBIT samt informationer om udbytte. Desuden ser vi på aspekter som aktier, markedskapitalisering, gæld, egenkapital og forpligtelser hos Clover Corporation. Hvis du søger mere detaljerede oplysninger om disse emner, tilbyder vi på vores undersider omfattende analyser: